Even Partial COVID-19 Vaccination Protects Nursing Home Residents | Geriatrics | JN Learning | AMA Ed Hub [Skip to Content]
[Skip to Content Landing]

Even Partial COVID-19 Vaccination Protects Nursing Home Residents

Educational Objective
To identify the key insights or developments described in this article
1 Credit CME

A CDC analysis has shown that a single dose of the Pfizer-BioNTech COVID-19 vaccine protected medically vulnerable nursing home residents as well as it did general adult populations that were evaluated in other efficacy and effectiveness studies.

The analysis helps fill a data gap about vaccine effectiveness in this high-risk group—generally older, frail adults with underlying health conditions—who were left out of COVID-19 vaccine trials. Excluding older adults from the trials raised questions about how well nursing home residents would respond to vaccination.

Sign in to take quiz and track your certificates

Buy This Activity

JN Learning™ is the home for CME and MOC from the JAMA Network. Search by specialty or US state and earn AMA PRA Category 1 CME Credit™ from articles, audio, Clinical Challenges and more. Learn more about CME/MOC

A CDC analysis has shown that a single dose of the Pfizer-BioNTech COVID-19 vaccine protected medically vulnerable nursing home residents as well as it did general adult populations that were evaluated in other efficacy and effectiveness studies.

The analysis helps fill a data gap about vaccine effectiveness in this high-risk group—generally older, frail adults with underlying health conditions—who were left out of COVID-19 vaccine trials. Excluding older adults from the trials raised questions about how well nursing home residents would respond to vaccination.

By analyzing the Pfizer-BioNTech vaccine’s performance during a late January outbreak at 2 Connecticut skilled nursing facilities, investigators from the CDC and the Connecticut Department of Public Health provided real-world data about this vulnerable population. A review of 463 residents’ charts showed that the vaccine was 63% effective during the period that stretched from 14 days after their first shot until 7 days after their second.

If you are not a JN Learning subscriber, you can either:
Subscribe to JN Learning for one year
Buy this activity
jn-learning_Modal_Multimedia_LoginSubscribe_Purchase
Close
If you are not a JN Learning subscriber, you can either:
Subscribe to JN Learning for one year
Buy this activity
jn-learning_Modal_Multimedia_LoginSubscribe_Purchase
Close
With a personal account, you can:
  • Access free activities and track your credits
  • Personalize content alerts
  • Customize your interests
  • Fully personalize your learning experience
Education Center Collection Sign In Modal Right
Close

Name Your Search

Save Search
Close
With a personal account, you can:
  • Track your credits
  • Personalize content alerts
  • Customize your interests
  • Fully personalize your learning experience
jn-learning_Modal_SaveSearch_NoAccess_Purchase
Close

Lookup An Activity

or

Close

My Saved Searches

You currently have no searches saved.

Close
With a personal account, you can:
  • Access free activities and track your credits
  • Personalize content alerts
  • Customize your interests
  • Fully personalize your learning experience
Education Center Collection Sign In Modal Right
Close